京津冀中药企业构建专利联盟重要性解析

详细信息    查看全文 | 推荐本文 |

英文篇名：Analysis on Importance of Patent Alliance in Beijing-Tianjin-Hebei Chinese Medical Enterprises 作者：杨旭杰 ; 裴晓华 ; 董尚朴 英文作者：YANG Xujie;PEI Xiaohua;DONG Shangpu;Hebei TCM College;Beijing University of Chinese Medicine;Fangshan Hospital of Beijing University of Chinese Medicine; 关键词：京津冀 ; 中药企业 ; 专利联盟 英文关键词：Beijing-Tianjin-Hebei;;Chinese medical enterprises;;patent alliance 中文刊名：XXYY 英文刊名：Chinese Journal of Information on Traditional Chinese Medicine 机构：河北中医学院;北京中医药大学;北京中医药大学房山医院; 出版日期：2019-02-15 出版单位：中国中医药信息杂志 年：2019 期：v.26;No.295 基金：北京市社会科学基金(17GLC062);; 中国博士后科学基金(2016M600973);; 河北省省级中医药发展资金重点任务(201816) 语种：中文; 页：XXYY201902004 页数：5 CN：02 ISSN：11-3519/R 分类号：20-24

摘要

目的探讨京、津、冀三地中药企业创建专利联盟之重要意义。方法收集京、津、冀三地中药企业所占有的专利资源,通过归类、清洗、分析之后,结合京、津、冀区域特点,探究京、津、冀中药企业联合构建专利联盟之重要意义。结果京、津、冀三地中药企业众多,实力梯度较大;专利集中于少数中药企业;河北区域中药企业专利数量有待提高。结论京、津、冀三地中药企业联合组建专利联盟,对于凝聚京、津、冀中药企业的合力,实现自我创新,建设专利池与药品标准,对抗药品垄断,以及将潜在的生产力转化为实际的医药经济实力等方面具有重要意义。
        Objective To explore the significance of creating patent alliance for Beijing-Tianjin-Hebei(Jing-Jin-Ji) Chinese medical enterprises. Methods Patent resources of Jing-Jin-Ji Chinese medical enterprises were collected. After classification, cleaning and analysis, combined with the characteristics of Jing-Jin-Ji, it is of great significance to explore the joint construction of patent alliances among Jing-Jin-Ji Chinese medical enterprises. Results There are many Chinese medical enterprises in Jing-Jin-Ji, and the strength gradient is quite large; patents are concentrated in a small number of Chinese medical enterprises while the number of patents of Chinese medical enterprises in Hebei need to increase. Conclusion Patent alliance for Jing-Jin-Ji Chinese medical enterprises has great significance in consolidating the synergy of Jing-Jin-Ji Chinese medical enterprises, achieving self-innovation, building patent pools and drug standards, countering drug monopoly, and converting potential productivity into the actual medical economic strength.

引文

[1]李娜,余翔.创新型国家战略下提升专利质量的综合策略探讨[J].华北电力大学学报:社会科学版,2018(1):82-87.
    [2]向美玲,曹阳.医药专利丛林引发制度滥用及其规制思考[J].现代商贸工业,2011,23(1):220-222.
    [3]朱翔华.欧盟委员会“关于标准必要专利的欧盟方法”对我国的启示[J].标准科学,2018(6):27-32.
    [4]赵迎辉.药品专利权与生命健康权的平衡[N].学习时报,2018-07-30(3).